68594-027 NDC - MNB RLP2086 SUBFAMILY A PROTEIN

Drug Information

  • Product NDC: 68594-027
  • Proprietary Name:
  • Non Proprietary Name: MnB rLP2086 subfamily A protein
  • Active Ingredient(s): .06 mg/.06mg NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT LP2086 A05 PROTEIN VARIANT ANTIGEN
  • Administration Route(s):
  • Dosage Form(s): SUSPENSION

Labeler Information

Field Name Field Value
Labeler Name: Boehringer Ingelheim RCV GmbH & Co KG
Product Type: VACCINE
FDA Application Number:
Marketing Category: DRUG FOR FURTHER PROCESSING
Start Marketing Date:10/29/2014

Package Information

No. Package Code Package Description Billing Unit
168594-027-995000 mg in 1 BAG (68594-027-99)

NDC Record

Field Name Field Value Definition
PRODUCT NDC68594-027The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEVACCINEIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
NON PROPRIETARY NAMEMnB rLP2086 subfamily A proteinThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMESUSPENSIONThe translation of the dosage form Code submitted by the firm.
START MARKETING DATE10/29/2014This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEDRUG FOR FURTHER PROCESSINGProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEBoehringer Ingelheim RCV GmbH & Co KGName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMENEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT LP2086 A05 PROTEIN VARIANT ANTIGENAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH.06 
ACTIVE INGRED UNITmg/.06mg 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 12/19/2025

Previous Code
Next Code